Lenalidomide for Patients With Myelofibrosis (MF)

• Status: Completed
• Trial end date: 2018-03-08

Summary

The goal of this clinical research study is to learn if lenalidomide in combination with prednisone can help to control myelofibrosis. The safety of lenalidomide and prednisone for the treatment of myelofibrosis will also be studied.

• Phase: Phase 2

Details

• Lead Sponsor: M.D. Anderson Cancer Center
• Collaborator: Celgene Corporation
• Treatments: Lenalidomide; Prednisone; Thalidomide